Histologically benign PI-RADS 4 and 5 lesions contain cancer-associated epigenetic alterations

Sadeleştirilmiş öğe sayfası
dc.contributor.authorSeref, Ceren
dc.contributor.authorAcar, Omer
dc.contributor.authorKilic, Mert
dc.contributor.authorVural, Metin
dc.contributor.authorSaglican, Yesim
dc.contributor.authorSarac, Hilal
dc.contributor.authorCoskun, Bilgen
dc.contributor.authorInce, Umit
dc.contributor.authorEsen, Tarik
dc.contributor.authorLack, Nathan A.
dc.date.accessioned2025-10-16T15:18:30Z
dc.date.issued2022
dc.identifier.doi10.1002/pros.24255
dc.identifier.otherWOS:000709406500001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/7158
dc.publisherWILEY
dc.sourcePROSTATE
dc.subjectepigenetics
dc.subjectmethylation biomarkers
dc.subjectMRI\\-guided biopsy
dc.subjectmultiparametric MRI
dc.subjectprostate cancer
dc.titleHistologically benign PI-RADS 4 and 5 lesions contain cancer-associated epigenetic alterations
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS